Your browser doesn't support javascript.
loading
Nosocomial candidiasis in Rio de Janeiro State: Distribution and fluconazole susceptibility profile
Neufeld, Paulo Murillo; Melhem, Marcia de Souza Carvalho; Szeszs, Maria Walderez; Ribeiro, Marcos Dornelas; Amorim, Efigênia de Lourdes Teixeira; Silva, Manuela da; Lazéra, Marcia dos Santos.
  • Neufeld, Paulo Murillo; Universidade Federal do Rio de Janeiro. Departamento de Análises Clínicas e Toxicológicas. Rio de Janeiro. BR
  • Melhem, Marcia de Souza Carvalho; Universidade Federal do Rio de Janeiro. Departamento de Análises Clínicas e Toxicológicas. Rio de Janeiro. BR
  • Szeszs, Maria Walderez; Universidade Federal do Rio de Janeiro. Departamento de Análises Clínicas e Toxicológicas. Rio de Janeiro. BR
  • Ribeiro, Marcos Dornelas; Universidade Federal do Rio de Janeiro. Departamento de Análises Clínicas e Toxicológicas. Rio de Janeiro. BR
  • Amorim, Efigênia de Lourdes Teixeira; Universidade Federal do Rio de Janeiro. Departamento de Análises Clínicas e Toxicológicas. Rio de Janeiro. BR
  • Silva, Manuela da; Universidade Federal do Rio de Janeiro. Departamento de Análises Clínicas e Toxicológicas. Rio de Janeiro. BR
  • Lazéra, Marcia dos Santos; Universidade Federal do Rio de Janeiro. Departamento de Análises Clínicas e Toxicológicas. Rio de Janeiro. BR
Braz. j. microbiol ; 46(2): 477-484, Apr-Jun/2015. tab
Article in English | LILACS | ID: lil-749709
ABSTRACT
One hundred and forty-one Candida species isolated from clinical specimens of hospitalized patients in Rio de Janeiro, Brazil, during 2002 to 2007, were analized in order to evaluate the distribution and susceptibility of these species to fluconazole. Candida albicans was the most frequent species (45.4%), followed by C. parapsilosis sensu lato (28.4%), C. tropicalis (14.2%), C. guilliermondii (6.4%), C. famata (2.8%), C. glabrata (1.4%), C. krusei (0.7%) and C. lambica (0.7%). The sources of fungal isolates were blood (47.5%), respiratory tract (17.7%), urinary tract (16.3%), skin and mucous membrane (7.1%), catheter (5.6%), feces (2.1%) and mitral valve tissue (0.7%). The susceptibility test was performed using the methodology of disk-diffusion in agar as recommended in the M44-A2 Document of the Clinical and Laboratory Standards Institute (CLSI). The majority of the clinical isolates (97.2%) was susceptible (S) to fluconazole, although three isolates (2.1%) were susceptible-dose dependent (S-DD) and one of them (0.7%) was resistant (R). The S-DD isolates were C. albicans, C. parapsilosis sensu lato and C. tropicalis. One isolate of C. krusei was resistant to fluconazole. This work documents the high susceptibility to fluconazole by Candida species isolated in Rio de Janeiro, Brazil.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Candida / Candidiasis / Fluconazole / Cross Infection / Antifungal Agents Type of study: Practice guideline Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: Braz. j. microbiol Journal subject: Microbiology Year: 2015 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Federal do Rio de Janeiro/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Candida / Candidiasis / Fluconazole / Cross Infection / Antifungal Agents Type of study: Practice guideline Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: Braz. j. microbiol Journal subject: Microbiology Year: 2015 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Federal do Rio de Janeiro/BR